Historique
Bulletin de Périodique
Journal of Substance Abuse Treatment , Vol.38, n°4 - June 2010
Paru le :
01/06/2010
Année
2010
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005, Pollack H. A., D'aunno T., p. 307-316.
- Predictors of motivation for abstinence at the end of outpatient substance abuse treatment, Laudet A. B., Stanick V., p. 317-327.
- Symptom complaints of patients prescribed either oral methadone or injectable heroin, Dursteler-Macfarland K. M., Fischer D. A., Mueller S., Schmid O., Moldovanyi A., Wiesbeck G. A., p. 328-337.
- High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin, Waizmann M., Ackermann G., p. 338-345.
- Posttraumatic stress disorder's role in integrated substance dependence and depression treatment outcomes, Norman S. B., Tate S. R., Wilkins K. C., Cummins K., Brown S. A., p. 346-355.
- Sober living houses for alcohol and drug dependence: 18-month outcomes, Polcin D. L., Korcha R. A., Bond J., Galloway G., p. 356-365.
- Subtyping of substance use disorders in a high-risk welfare-to-work sample: a latent class analysis, Schwartz B., Wetzler S., Swanson A., Sung S. C., p. 366-374.
- Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment, Epperson M. W., Khan M. R., Miller D. P., Perron B. E., El-Bassel N., Gilbert L., p. 375-383.
- Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder, Williams J. M., Steinberg M. L., Zimmermann M. H., Gandhi K. K., Stipelman B., Budsock P. D., et al., p. 384-393.
- Smoking outcome by psychiatric history after behavioral and varenicline treatment, Mcclure J. B., Swan G. E., Catz S. L., Jack L., Javitz H., Mcafee T., et al., p. 394-402.
- Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment, Megarbane B., Buisine A., Jacobs F., Resiere D., Chevillard L., Vicaut E., et al., p. 403-407.
- Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study, Oviedo-Joekes E., Guh D., Brissette S., Marsh D. C., Nosyk B., Krausz M., et al., p. 408-411.
- HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005, Pollack H. A., D'aunno T., p. 307-316.
- Predictors of motivation for abstinence at the end of outpatient substance abuse treatment, Laudet A. B., Stanick V., p. 317-327.
- Symptom complaints of patients prescribed either oral methadone or injectable heroin, Dursteler-Macfarland K. M., Fischer D. A., Mueller S., Schmid O., Moldovanyi A., Wiesbeck G. A., p. 328-337.
- High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin, Waizmann M., Ackermann G., p. 338-345.
- Posttraumatic stress disorder's role in integrated substance dependence and depression treatment outcomes, Norman S. B., Tate S. R., Wilkins K. C., Cummins K., Brown S. A., p. 346-355.
- Sober living houses for alcohol and drug dependence: 18-month outcomes, Polcin D. L., Korcha R. A., Bond J., Galloway G., p. 356-365.
- Subtyping of substance use disorders in a high-risk welfare-to-work sample: a latent class analysis, Schwartz B., Wetzler S., Swanson A., Sung S. C., p. 366-374.
- Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment, Epperson M. W., Khan M. R., Miller D. P., Perron B. E., El-Bassel N., Gilbert L., p. 375-383.
- Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder, Williams J. M., Steinberg M. L., Zimmermann M. H., Gandhi K. K., Stipelman B., Budsock P. D., et al., p. 384-393.
- Smoking outcome by psychiatric history after behavioral and varenicline treatment, Mcclure J. B., Swan G. E., Catz S. L., Jack L., Javitz H., Mcafee T., et al., p. 394-402.
- Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment, Megarbane B., Buisine A., Jacobs F., Resiere D., Chevillard L., Vicaut E., et al., p. 403-407.
- Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study, Oviedo-Joekes E., Guh D., Brissette S., Marsh D. C., Nosyk B., Krausz M., et al., p. 408-411.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
K. M. DÜRSTELER-MacFARLAND ;
D. A. FISCHER ;
S. MUELLER ;
O. SCHMID ;
A. MOLDOVANYI ;
G. A. WIESBECK
|
2010
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Many methadone patients and untreated heroin users have an ambivalent attitude toward methadone maintenance. This may be a result of the widespread belief that methadone produces various side effects not found with heroin. This study compared th[...]
D. L. POLCIN ;
R. A. KORCHA ;
J. BOND ;
G. G. GALLOWAY
|
2010
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Objective
A major challenge facing many individuals attempting to abstain from substances is finding a stable living environment that supports sustained recovery. Sober living houses (SLHs) are alcohol- and drug-free living environments that su[...]
B. MEGARBANE ;
A. BUISINE ;
F. JACOBS ;
D. RESIERE ;
L. CHEVILLARD ;
E. VICAUT ;
F. J. BAUD
|
2010
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Buprenorphine is a partial opioid agonist with a “ceiling effect” for respiratory depression. Despite this, it has been associated with severe overdoses. Conflicting data exist regarding its response in overdose to naloxone. We compared clinical[...]
E. OVIEDO-JOEKES ;
D. GUH ;
S. BRISSETTE ;
D. C. MARSH ;
B. NOSYK ;
M. K. KRAUSZ ;
A. A. ANIS ;
M. T. SCHECHTER
|
2010
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Dans Journal of Substance Abuse Treatment (Vol.38, n°4, June 2010) Article : Périodique
Using data from the North American Opioid Maintenance Initiative study, a Phase III randomized and parallel arm trial, this pilot study is aimed at testing if treatment response with injectable hydromorphone differs compared to diacetylmorphine [...]